IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Wildcat Capital Management, LLC

Q1 2025 Holdings

Filed 2025-05-02 | 8 holdings | $187.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Frontier Group Hldgs Inc(ULCC)COM35909R108$121.8M28,061,35165.0%
RLX Technology Inc(RLX)SPONSORED ADS74969N103$33.9M18,046,19518.1%
Acuren Corp(TIC)COM00510N102$16.7M1,500,0008.9%
Urogen Pharma LTD(URGN)COMM96088105$5.5M495,6062.9%
Allogene Therapeutics Inc(ALLO)COM019770106$4.3M2,920,7872.3%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$4.1M281,8592.2%
Kronos BIO Inc(KRON1USD)COM50107A104$1.1M1,297,9590.6%
Silexion Therapeutics CorpSHS NEWG1281K122$124.8K113,4280.1%